BIOMAB EGFR – Nimotuzumab Injection 50 mg

Biomab EGFR (Nimotuzumab Injection) is a monoclonal antibody that reacts on the Epidermal Growth Factor Receptor (EGFR). It is applied in treating cancer to prevent the growth of tumor and the effectiveness of therapy. It is associated with a high safety profile and a specific action, and it is widely used in oncology facilities.

COMPOSITION  :  Nimotuzumab – 50 mg

Manufacturer: Biocon Biologics
Pack Size: 4 × 10 mL vials
IV use only

DOSAGE

• As directed by an Oncologist

• Administered via IV infusion only

STORAGE CONDITIONS

• Store at 2°C – 8°C

• Do not freeze